Status:
RECRUITING
Early Intervention to Protect the Mother-Child Relationship After Postpartum Depression
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Post Partum Depression
Eligibility:
FEMALE
18-100 years
Phase:
NA
Brief Summary
Postpartum depression (PPD) may impair the mother-infant relationship and lead to both short and long-term suboptimal development of the baby. This study aims to evaluate the effectiveness of a target...
Detailed Description
Post-partum depression (PPD) is the most common psychological pathology following childbirth and affects 12% of women in France. This pathology may impair the mother-infant relationship and lead to su...
Eligibility Criteria
Inclusion
- Inclusion criteria regarding the mother:
- Person affiliated or beneficiary of a social security plan;
- Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research);
- Woman who gave birth in one of the maternity hospitals participating in the study;
- Diagnosis of postpartum depression made by the perinatal psychiatry team according to the clinical criteria of the DSM-5;
- Time to onset of depressive symptoms within the first 12 months after childbirth;
- Treatment for postpartum depression that started at least 8 weeks ago with improved mood as assessed by the psychiatrist.
- Inclusion criteria for the baby:
- Baby aged less than 1 year at inclusion;
- Twins will be able to participate in the study and benefit from the interventions;
- Non-inclusion criteria concerning the mother:
- Uncontrolled substance use disorder;
- Presence of suicidal ideas at inclusion;
- Manic episode of a bipolar disease
- Psychiatric pathology decompensated upon inclusion and corresponding to the following list: Schizophrenic disorder, Schizoaffective disorder, Mood disorders with psychotic symptoms;
- Non French speaker.
- Non-inclusion criteria for the baby:
- \- Baby hospitalized or having sustained medical care upon inclusion in the context of a somatic pathology.
Exclusion
Key Trial Info
Start Date :
December 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT05209789
Start Date
December 18 2023
End Date
December 1 2026
Last Update
February 15 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Bordeaux Public Hospital
Bordeaux, France
2
Havre Public Hospital Maternity
Le Havre, France
3
Reims Public Hospital Maternity
Reims, France
4
Rouen Public Hospital Maternity
Rouen, France